Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jon Matsumura

Concepts (463)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Vessel Prosthesis Implantation
88
2026
219
14.990
Why?
Aortic Aneurysm, Abdominal
73
2026
164
11.780
Why?
Blood Vessel Prosthesis
60
2026
133
10.410
Why?
Endovascular Procedures
53
2026
390
9.970
Why?
Aortic Aneurysm, Thoracic
35
2026
135
7.750
Why?
Stents
68
2025
554
7.560
Why?
Aorta, Thoracic
27
2026
284
4.500
Why?
Carotid Stenosis
23
2024
103
3.530
Why?
Prosthesis Design
41
2026
358
3.380
Why?
Iliac Aneurysm
9
2024
17
3.280
Why?
Vascular Surgical Procedures
19
2018
352
2.370
Why?
Endarterectomy, Carotid
14
2024
63
2.180
Why?
Aortography
18
2025
54
2.120
Why?
Vascular System Injuries
6
2024
79
2.100
Why?
Tomography, X-Ray Computed
37
2025
2786
1.980
Why?
Treatment Outcome
97
2026
11821
1.910
Why?
Aortic Diseases
9
2025
125
1.900
Why?
Iliac Artery
11
2024
53
1.800
Why?
Angioplasty
12
2017
49
1.780
Why?
Computed Tomography Angiography
8
2024
151
1.760
Why?
Aortic Rupture
13
2026
28
1.720
Why?
Time Factors
57
2026
7109
1.620
Why?
Aortic Aneurysm
9
2024
69
1.530
Why?
Stroke
18
2024
1287
1.450
Why?
Aged, 80 and over
58
2026
8391
1.390
Why?
Angioplasty, Balloon
9
2013
92
1.360
Why?
Aged
108
2026
26432
1.290
Why?
Aorta, Abdominal
9
2025
51
1.130
Why?
Postoperative Complications
35
2025
3034
1.080
Why?
Risk Factors
45
2026
10921
1.080
Why?
Endoleak
11
2025
16
1.040
Why?
Sarcopenia
2
2019
100
1.040
Why?
Prosthesis Failure
11
2017
126
0.950
Why?
Prospective Studies
39
2026
8123
0.940
Why?
Middle Aged
82
2026
36619
0.920
Why?
Vascular Patency
13
2025
115
0.900
Why?
Humans
184
2026
146342
0.890
Why?
Subclavian Artery
6
2022
28
0.890
Why?
Male
123
2026
73396
0.860
Why?
Myocardial Infarction
5
2024
1215
0.780
Why?
United States
41
2025
16136
0.780
Why?
Female
116
2026
79499
0.770
Why?
Femoral Artery
4
2013
183
0.740
Why?
Predictive Value of Tests
11
2025
2113
0.740
Why?
Vena Cava Filters
5
2023
68
0.720
Why?
Ulcer
3
2014
37
0.680
Why?
Risk Assessment
21
2024
3712
0.660
Why?
Population Surveillance
2
2021
481
0.650
Why?
Foreign-Body Migration
3
2017
32
0.620
Why?
Alloys
3
2024
36
0.600
Why?
Ischemia
5
2018
421
0.600
Why?
Retrospective Studies
44
2025
17438
0.590
Why?
Popliteal Artery
4
2015
60
0.570
Why?
Peripheral Arterial Disease
2
2018
507
0.570
Why?
Marfan Syndrome
1
2019
44
0.570
Why?
Psoas Muscles
1
2018
24
0.560
Why?
Frailty
2
2019
208
0.560
Why?
Reoperation
13
2020
645
0.550
Why?
Body Composition
2
2019
689
0.540
Why?
Doxycycline
4
2025
61
0.510
Why?
Societies, Medical
5
2020
907
0.510
Why?
Chlorhexidine
1
2017
24
0.500
Why?
Decontamination
1
2017
28
0.500
Why?
Anti-Infective Agents, Local
1
2017
40
0.490
Why?
Health Care Costs
3
2014
423
0.480
Why?
Elective Surgical Procedures
8
2020
216
0.470
Why?
Wounds, Nonpenetrating
6
2024
305
0.460
Why?
Embolization, Therapeutic
2
2022
246
0.440
Why?
Infection Control
1
2017
174
0.440
Why?
Radiography, Interventional
5
2019
128
0.430
Why?
Education, Medical, Continuing
2
2014
130
0.430
Why?
Thoracic Injuries
3
2024
69
0.430
Why?
Follow-Up Studies
26
2024
5439
0.420
Why?
Program Development
2
2014
371
0.400
Why?
Patient Readmission
3
2014
778
0.400
Why?
Lower Extremity
1
2018
453
0.390
Why?
Vascular Diseases
2
2014
252
0.390
Why?
Surgical Wound Infection
1
2017
349
0.390
Why?
Vascular Calcification
2
2025
109
0.380
Why?
Kaplan-Meier Estimate
10
2019
970
0.370
Why?
Health Expenditures
1
2014
198
0.370
Why?
Carotid Artery Diseases
3
2005
70
0.370
Why?
Congresses as Topic
1
2014
226
0.370
Why?
Clinical Trials as Topic
5
2026
1064
0.360
Why?
Skin
1
2017
701
0.360
Why?
Asymptomatic Diseases
5
2024
102
0.350
Why?
Patient Selection
7
2021
728
0.350
Why?
Embolic Protection Devices
1
2012
12
0.350
Why?
Constriction, Pathologic
7
2023
240
0.330
Why?
Minimally Invasive Surgical Procedures
7
2009
196
0.330
Why?
Thoracic Outlet Syndrome
3
2001
14
0.330
Why?
Arterial Occlusive Diseases
3
2008
88
0.330
Why?
Pulmonary Embolism
2
2005
246
0.320
Why?
Thromboembolism
1
2012
129
0.320
Why?
Severity of Illness Index
9
2024
2921
0.310
Why?
Intracranial Embolism
1
2010
34
0.310
Why?
Ultrasonography, Doppler, Duplex
10
2017
39
0.310
Why?
Ultrasonography, Interventional
3
2001
163
0.310
Why?
Filtration
1
2010
68
0.310
Why?
Peripheral Vascular Diseases
2
2004
102
0.310
Why?
Survival Rate
11
2026
2092
0.310
Why?
Disease Progression
6
2023
2867
0.300
Why?
Venous Thrombosis
5
2005
199
0.290
Why?
Muscle, Skeletal
1
2019
1818
0.290
Why?
Adult
37
2024
41087
0.280
Why?
Chi-Square Distribution
5
2014
517
0.280
Why?
Radiography
7
2012
861
0.280
Why?
Stainless Steel
2
2024
19
0.270
Why?
Iliac Vein
2
2006
13
0.270
Why?
Thrombosis
4
2018
398
0.260
Why?
Health Status
4
2026
827
0.260
Why?
Regional Blood Flow
4
2018
507
0.260
Why?
Paraparesis
2
2008
7
0.250
Why?
Spinal Cord Ischemia
2
2010
60
0.250
Why?
Hospitals, University
1
2007
178
0.240
Why?
Graft Occlusion, Vascular
4
2018
39
0.240
Why?
Blood Proteins
2
2025
239
0.230
Why?
Endpoint Determination
1
2026
84
0.230
Why?
Angiography
5
2017
206
0.230
Why?
Hospital Mortality
4
2020
1051
0.230
Why?
Ankle Brachial Index
2
2018
41
0.230
Why?
Epidemiologic Research Design
1
2005
27
0.230
Why?
Length of Stay
6
2024
1358
0.220
Why?
Amino Acid Oxidoreductases
1
2024
19
0.220
Why?
Protein-Lysine 6-Oxidase
1
2024
14
0.220
Why?
Retreatment
2
2021
79
0.210
Why?
Erectile Dysfunction
2
2023
35
0.210
Why?
Incisional Hernia
1
2024
8
0.210
Why?
Femoral Vein
3
2001
36
0.200
Why?
Matrix Metalloproteinase 3
1
2023
27
0.190
Why?
Reproducibility of Results
4
2025
3416
0.190
Why?
Preoperative Care
3
2017
396
0.190
Why?
Multicenter Studies as Topic
3
2014
417
0.190
Why?
Matrix Metalloproteinase 9
1
2023
128
0.190
Why?
Registries
3
2026
2400
0.180
Why?
Paraplegia
4
2011
60
0.180
Why?
Catheterization, Peripheral
3
2009
116
0.180
Why?
Comorbidity
7
2019
1665
0.180
Why?
Carotid Artery, Internal
5
2008
45
0.180
Why?
Equipment Design
6
2011
520
0.180
Why?
Prosthesis Implantation
2
2002
156
0.170
Why?
Aftercare
2
2020
225
0.170
Why?
Double-Blind Method
3
2023
2070
0.170
Why?
Odds Ratio
3
2014
1077
0.170
Why?
Feasibility Studies
7
2022
1135
0.160
Why?
Patients' Rooms
1
2000
13
0.160
Why?
Hyperglycemia
1
2024
384
0.160
Why?
Eligibility Determination
1
2021
73
0.160
Why?
Logistic Models
4
2015
2126
0.160
Why?
Collateral Circulation
2
2010
20
0.160
Why?
Abdominal Oblique Muscles
1
2019
1
0.150
Why?
Intercostal Muscles
1
2019
4
0.150
Why?
Clinical Competence
6
2019
1272
0.150
Why?
Cause of Death
4
2019
456
0.150
Why?
Rectus Abdominis
1
2019
16
0.150
Why?
United States Food and Drug Administration
3
2009
208
0.150
Why?
Superficial Back Muscles
1
2019
16
0.150
Why?
Oleic Acids
1
1999
12
0.150
Why?
Spinal Fusion
1
2022
265
0.150
Why?
Credentialing
1
2019
21
0.150
Why?
Cost-Benefit Analysis
2
2020
640
0.150
Why?
Specialties, Surgical
1
2020
88
0.140
Why?
Aneurysm, Ruptured
2
2013
38
0.140
Why?
Netherlands
3
2026
85
0.140
Why?
Observer Variation
2
2018
356
0.140
Why?
Proteomics
1
2025
1203
0.140
Why?
Frail Elderly
1
2019
141
0.140
Why?
Phosphatidylcholines
1
1999
131
0.140
Why?
Liposomes
1
2000
269
0.140
Why?
Genetic Therapy
1
2000
303
0.140
Why?
Protease Inhibitors
1
2019
103
0.140
Why?
Disease-Free Survival
3
2017
778
0.140
Why?
Age Factors
4
2026
3347
0.130
Why?
Electronic Mail
1
2018
63
0.130
Why?
Surgeons
1
2022
351
0.130
Why?
Curriculum
1
2005
1079
0.130
Why?
Gene Transfer Techniques
1
1999
185
0.130
Why?
Quality of Life
5
2026
3200
0.130
Why?
Neck Muscles
1
1997
21
0.130
Why?
Ribs
1
1997
35
0.130
Why?
Limb Salvage
1
2018
74
0.130
Why?
Anatomic Landmarks
1
2017
31
0.130
Why?
Blood Vessels
1
1999
164
0.130
Why?
Clavicle
1
1997
38
0.130
Why?
Anti-Bacterial Agents
2
2020
1942
0.130
Why?
Administration, Cutaneous
1
2017
128
0.120
Why?
Critical Illness
3
2018
908
0.120
Why?
Axillary Artery
1
1996
14
0.120
Why?
Bile Pigments
1
1996
2
0.120
Why?
Quality Assurance, Health Care
2
2019
349
0.120
Why?
Endothelium, Vascular
2
2000
952
0.120
Why?
Cholagogues and Choleretics
1
1996
5
0.120
Why?
Bile
1
1996
26
0.120
Why?
Cholelithiasis
1
1996
37
0.120
Why?
Analysis of Variance
2
2016
1298
0.120
Why?
Incidence
7
2016
2936
0.110
Why?
Biomarkers
2
2025
4340
0.110
Why?
Randomized Controlled Trials as Topic
4
2024
1763
0.110
Why?
Anti-Inflammatory Agents
1
2019
474
0.110
Why?
Antioxidants
1
2019
544
0.110
Why?
Sex Factors
3
2026
2107
0.110
Why?
Survival Analysis
6
2016
1378
0.110
Why?
Spinal Injuries
1
1995
62
0.110
Why?
Antihypertensive Agents
1
2019
519
0.110
Why?
Evidence-Based Medicine
4
2017
731
0.100
Why?
Chicago
3
2011
62
0.100
Why?
Blood Glucose
1
2024
2360
0.100
Why?
Prosthesis-Related Infections
2
2008
100
0.100
Why?
Intermittent Claudication
1
2015
121
0.100
Why?
Wisconsin
1
2013
102
0.100
Why?
Hospital Costs
1
2014
131
0.100
Why?
Hypertension
2
2021
1272
0.100
Why?
Taurocholic Acid
1
1993
8
0.100
Why?
Physician-Patient Relations
1
2018
597
0.100
Why?
Parenteral Nutrition, Total
1
1993
27
0.100
Why?
Imaging, Three-Dimensional
2
2016
582
0.100
Why?
Gastrointestinal Diseases
1
1995
220
0.090
Why?
Aneurysm
2
2003
37
0.090
Why?
Diabetes Mellitus
1
2021
1101
0.090
Why?
Intestinal Absorption
1
1993
103
0.090
Why?
Clinical Decision-Making
3
2021
365
0.090
Why?
Tertiary Care Centers
1
2013
196
0.090
Why?
Leg
3
1999
246
0.090
Why?
Intraoperative Complications
3
2019
157
0.090
Why?
Ileum
1
1993
112
0.090
Why?
Postoperative Care
1
2014
301
0.090
Why?
Europe
1
2013
421
0.090
Why?
Device Approval
2
2009
19
0.090
Why?
Communication
1
2018
980
0.090
Why?
Permeability
2
2009
166
0.090
Why?
Catheters
1
2011
73
0.090
Why?
Viscera
1
2011
17
0.080
Why?
Proportional Hazards Models
3
2009
1331
0.080
Why?
Acute Disease
4
2024
1038
0.080
Why?
Bayes Theorem
2
2023
426
0.080
Why?
Vertebrobasilar Insufficiency
1
2010
9
0.080
Why?
Exercise Tolerance
1
2013
289
0.080
Why?
Aneurysm, False
1
2011
46
0.080
Why?
Residence Characteristics
1
2013
385
0.080
Why?
Databases as Topic
1
2010
70
0.080
Why?
Cardiovascular Diseases
1
2022
2219
0.080
Why?
Research Design
3
2009
1143
0.080
Why?
Multivariate Analysis
1
2013
1543
0.080
Why?
Exercise Test
1
2013
637
0.080
Why?
Electronic Health Records
1
2018
1210
0.080
Why?
Controlled Clinical Trials as Topic
1
2009
26
0.080
Why?
Young Adult
5
2024
14330
0.080
Why?
United States Department of Veterans Affairs
1
2014
777
0.080
Why?
Radiography, Abdominal
2
2001
44
0.080
Why?
Hospitals, Urban
1
2010
140
0.080
Why?
Ischemic Attack, Transient
2
2009
71
0.070
Why?
Longitudinal Studies
1
2017
3017
0.070
Why?
Ambulatory Care
1
2014
628
0.070
Why?
Genes, Reporter
2
2000
275
0.070
Why?
Socioeconomic Factors
1
2013
1327
0.070
Why?
Dilatation, Pathologic
2
1999
60
0.070
Why?
Porosity
1
2009
95
0.070
Why?
Plasmids
2
2000
373
0.070
Why?
Telemedicine
1
2018
966
0.070
Why?
Benchmarking
1
2010
193
0.070
Why?
Extremities
1
2009
142
0.070
Why?
Rupture
1
2009
91
0.070
Why?
Carotid Arteries
1
2010
206
0.070
Why?
Ultrasonography
4
2014
788
0.070
Why?
General Surgery
2
2014
217
0.070
Why?
Aorta
2
2022
440
0.070
Why?
Anesthesiology
1
1990
178
0.070
Why?
Treatment Failure
2
2020
361
0.070
Why?
Coronary Artery Bypass
2
2000
269
0.070
Why?
Carotid Artery Thrombosis
1
2007
6
0.060
Why?
Organ Size
2
2020
465
0.060
Why?
Equipment Safety
2
2009
38
0.060
Why?
Calcinosis
1
2009
231
0.060
Why?
Animals
6
2024
38107
0.060
Why?
Patient Discharge
1
2013
997
0.060
Why?
Delivery of Health Care
1
2014
947
0.060
Why?
Image Processing, Computer-Assisted
2
2004
778
0.060
Why?
Polymorphism, Single Nucleotide
1
2014
2240
0.060
Why?
Arm
2
1997
111
0.060
Why?
Brain Ischemia
1
2010
362
0.060
Why?
Prostheses and Implants
1
2007
137
0.060
Why?
Polyesters
1
2006
76
0.060
Why?
Clinical Trials, Phase II as Topic
1
2005
74
0.060
Why?
Hematoma
1
2005
62
0.060
Why?
Vena Cava, Inferior
2
2023
80
0.050
Why?
Recurrence
3
2017
1133
0.050
Why?
Practice Guidelines as Topic
4
2010
1591
0.050
Why?
Health Status Indicators
1
2005
167
0.050
Why?
Renal Veins
1
2004
16
0.050
Why?
Mesenteric Artery, Superior
1
2004
28
0.050
Why?
Cohort Studies
4
2026
6077
0.050
Why?
Hernia, Ventral
1
2004
33
0.050
Why?
United Kingdom
2
2003
377
0.050
Why?
High-Throughput Screening Assays
1
2025
179
0.050
Why?
Extracellular Matrix Proteins
1
2024
156
0.050
Why?
Matrix Metalloproteinase Inhibitors
1
2023
16
0.050
Why?
Fluoroscopy
2
2001
179
0.050
Why?
Nephrectomy
1
2004
172
0.050
Why?
Data Collection
1
2006
650
0.050
Why?
Myocytes, Smooth Muscle
1
2024
271
0.050
Why?
Vascular Remodeling
1
2024
208
0.050
Why?
Cerebrovascular Disorders
2
2000
103
0.050
Why?
Leadership
1
2007
414
0.050
Why?
Lumbosacral Region
1
2022
58
0.050
Why?
Mass Spectrometry
1
2025
729
0.050
Why?
Cells, Cultured
2
2000
4118
0.050
Why?
Head and Neck Neoplasms
1
2007
563
0.050
Why?
Illinois
3
2008
47
0.040
Why?
Learning Curve
1
2022
71
0.040
Why?
Muscle, Smooth, Vascular
1
2024
449
0.040
Why?
Quality of Health Care
1
2007
702
0.040
Why?
Arteries
1
2023
261
0.040
Why?
Mesenteric Vascular Occlusion
1
2001
5
0.040
Why?
Time
1
2002
85
0.040
Why?
Delphi Technique
1
2023
350
0.040
Why?
Device Removal
1
2023
149
0.040
Why?
Perfusion
1
2023
255
0.040
Why?
England
1
2001
106
0.040
Why?
Maxillary Sinus Neoplasms
1
2001
6
0.040
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2025
449
0.040
Why?
Mesenteric Veins
1
2001
28
0.040
Why?
Substance-Related Disorders
1
1990
1100
0.040
Why?
Health Status Disparities
1
2024
322
0.040
Why?
Angiotensin Receptor Antagonists
1
2021
115
0.040
Why?
Gene Targeting
1
2000
76
0.040
Why?
Sensitivity and Specificity
2
2005
1998
0.040
Why?
Costs and Cost Analysis
1
2001
217
0.040
Why?
Peritoneum
1
2000
44
0.040
Why?
Cerebral Angiography
1
2000
121
0.040
Why?
Biomedical Research
1
2007
729
0.040
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2021
228
0.040
Why?
Disease Models, Animal
2
2024
4580
0.040
Why?
Radiotherapy
1
2001
209
0.040
Why?
Troponin T
1
2000
63
0.040
Why?
Internship and Residency
1
1990
1281
0.040
Why?
Cation Exchange Resins
1
1999
7
0.040
Why?
Intracranial Aneurysm
1
2000
105
0.040
Why?
Injury Severity Score
2
2013
572
0.040
Why?
Spermine
1
1999
29
0.040
Why?
Diagnosis, Differential
2
2001
1503
0.040
Why?
Rabbits
1
2000
651
0.040
Why?
Arteriovenous Shunt, Surgical
1
1999
21
0.040
Why?
Emergency Treatment
1
2020
122
0.040
Why?
Luciferases
1
1999
153
0.040
Why?
Point-of-Care Systems
1
2001
185
0.040
Why?
Monitoring, Intraoperative
1
1999
66
0.040
Why?
Echocardiography, Transesophageal
1
2000
132
0.040
Why?
Veins
1
1999
68
0.040
Why?
Endoscopy
1
2001
316
0.030
Why?
Prognosis
3
2015
4351
0.030
Why?
Practice Patterns, Physicians'
3
2019
1408
0.030
Why?
Postoperative Period
1
1999
355
0.030
Why?
Myocardial Contraction
1
2000
292
0.030
Why?
Drug Carriers
1
1999
138
0.030
Why?
Glycine
1
1999
184
0.030
Why?
Arteriosclerosis
1
1998
82
0.030
Why?
Subclavian Vein
1
1997
15
0.030
Why?
Surgical Flaps
1
1999
140
0.030
Why?
Administration, Oral
1
2020
872
0.030
Why?
Anastomosis, Surgical
1
1998
164
0.030
Why?
Heparin, Low-Molecular-Weight
1
1997
37
0.030
Why?
Transfection
1
1999
916
0.030
Why?
Retroperitoneal Neoplasms
1
1997
28
0.030
Why?
Multiple Trauma
2
2010
118
0.030
Why?
Intraoperative Care
1
1997
68
0.030
Why?
Hemodynamics
2
2000
1114
0.030
Why?
Cholic Acids
1
1996
13
0.030
Why?
Recombinant Proteins
1
1999
1361
0.030
Why?
Mice, Inbred C57BL
2
2024
6034
0.030
Why?
Veterans
1
2008
1650
0.030
Why?
Carcinoma, Squamous Cell
1
2001
628
0.030
Why?
Atherosclerosis
1
2019
410
0.030
Why?
Taurine
1
1996
41
0.030
Why?
Lipid Metabolism
1
1999
533
0.030
Why?
Movement
1
1997
290
0.030
Why?
Wound Healing
1
1998
354
0.030
Why?
Dose-Response Relationship, Drug
1
1999
2022
0.030
Why?
Anticoagulants
2
2016
746
0.030
Why?
Contrast Media
1
1998
493
0.030
Why?
Bile Acids and Salts
1
1996
163
0.030
Why?
Myocardium
1
2000
948
0.030
Why?
Tumor Necrosis Factor-alpha
1
1999
1224
0.030
Why?
Gene Expression
1
1999
1463
0.030
Why?
Sarcoma
1
1997
209
0.030
Why?
Respiratory Insufficiency
1
1998
330
0.030
Why?
Dogs
1
1996
517
0.030
Why?
Prevalence
1
2001
2861
0.030
Why?
Neoplasm Recurrence, Local
1
2001
1160
0.030
Why?
Lipids
1
1999
714
0.030
Why?
Databases, Factual
1
2019
1493
0.020
Why?
Accidents, Traffic
2
2005
193
0.020
Why?
Swine, Miniature
1
1993
88
0.020
Why?
Mass Screening
1
2001
1307
0.020
Why?
Least-Squares Analysis
1
2012
73
0.020
Why?
Blood Flow Velocity
2
2005
419
0.020
Why?
DNA
1
1999
1421
0.020
Why?
Random Allocation
1
1993
366
0.020
Why?
Infusions, Intravenous
1
1993
432
0.020
Why?
Quality-Adjusted Life Years
1
2012
122
0.020
Why?
Magnetic Resonance Imaging
3
2003
3926
0.020
Why?
Case-Control Studies
2
2014
3647
0.020
Why?
Physician Impairment
1
1990
15
0.020
Why?
Cross-Sectional Studies
1
2022
5899
0.020
Why?
Polytetrafluoroethylene
2
2003
24
0.020
Why?
Swine
1
1993
821
0.020
Why?
Mice
2
2024
18297
0.020
Why?
Blood Component Transfusion
1
2010
99
0.020
Why?
Product Surveillance, Postmarketing
1
2009
74
0.020
Why?
Confidence Intervals
1
2010
329
0.020
Why?
Probability
1
2010
309
0.020
Why?
Infant
1
2023
10114
0.020
Why?
Morbidity
1
2009
319
0.020
Why?
Advisory Committees
1
2009
228
0.020
Why?
Medicare
1
2014
920
0.020
Why?
Suture Techniques
1
2008
138
0.020
Why?
Regression Analysis
1
2010
999
0.020
Why?
Postoperative Hemorrhage
1
2008
106
0.020
Why?
Catheterization
1
2007
179
0.010
Why?
Guideline Adherence
1
2010
594
0.010
Why?
Phenotype
1
2014
3206
0.010
Why?
Surveys and Questionnaires
1
2018
6073
0.010
Why?
Genetic Predisposition to Disease
1
2014
2488
0.010
Why?
Pyelonephritis, Xanthogranulomatous
1
2004
3
0.010
Why?
Ligation
1
2004
88
0.010
Why?
Thrombectomy
1
2004
79
0.010
Why?
Escherichia coli Infections
1
2004
125
0.010
Why?
Transplantation, Autologous
1
2004
306
0.010
Why?
Washington
1
2003
157
0.010
Why?
Popliteal Vein
1
2001
5
0.010
Why?
Protein S Deficiency
1
2001
8
0.010
Why?
Antithrombin III Deficiency
1
2001
8
0.010
Why?
Adolescent
2
2006
22557
0.010
Why?
Chronic Disease
1
2008
1827
0.010
Why?
Protein C Deficiency
1
2001
11
0.010
Why?
Hospitalization
1
2012
2475
0.010
Why?
Trismus
1
2001
2
0.010
Why?
Hospital Charges
1
2001
45
0.010
Why?
Causality
1
2001
128
0.010
Why?
Cellulitis
1
2001
55
0.010
Why?
Radiotherapy Dosage
1
2001
289
0.010
Why?
Obesity, Morbid
1
2004
287
0.010
Why?
Creatine Kinase
1
2000
70
0.010
Why?
Necrosis
1
2001
243
0.010
Why?
Child, Preschool
1
1995
11913
0.010
Why?
Eye Diseases
1
2001
100
0.010
Why?
Chemotherapy, Adjuvant
1
2001
429
0.010
Why?
Isoenzymes
1
2000
294
0.010
Why?
Anesthesia, General
1
2000
124
0.010
Why?
Rectum
1
2000
180
0.010
Why?
Myocardial Ischemia
1
2000
286
0.010
Why?
Cardiopulmonary Bypass
1
2000
217
0.010
Why?
Blindness
1
1998
51
0.010
Why?
Combined Modality Therapy
1
2001
1271
0.010
Why?
Drug Evaluation
1
1997
78
0.010
Why?
Neoplasm Staging
1
2001
1488
0.010
Why?
Electrocardiography
1
2000
667
0.010
Why?
Diabetes Complications
1
1998
219
0.010
Why?
Heparin
1
1997
247
0.010
Why?
Decision Making
1
2003
993
0.010
Why?
Child
1
1995
22693
0.010
Why?
Algorithms
1
2001
1849
0.010
Why?
Hemorrhage
1
1998
825
0.010
Why?
Smoking
1
1998
1486
0.010
Why?
Matsumura's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)